About

About Energenesis Biomedical Co., Ltd. Energenesis Biomedical, founded in 2012, is a biotech company publicly listed on the Taiwan Stock Exchange Corporation (TWSE: 6657). With over a decade of commitment, our team has pioneered the ENERGI-Platform, a novel approach using small-molecule drugs to boost cellular energy levels. This technology activates self-healing mechanisms within cells, empowering us to explore innovative ways of addressing challenging diseases in neurodegenerative disorders and the areas of unmet medical needs. ENERGI-F705PD : oral medicine for Parkinson’s disease (Phase I) ENERGI-F703DFU: gel for Diabetic foot ulcers (Phase III) ENERGI-F701: hair tonic for Alopecia (Phase II) ENERGI-F703EB: cream for Epidermolysis Bullosa (in preparation for Phase II, granted ODD&RPD) NOT INTERESTED IN CHARGEABLE SERVICE.